7729 logo

Steminent Biotherapeutics Inc. Stock Price

TPEX:7729 Community·NT$5.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7729 Share Price Performance

NT$0
-21.30 (-100.00%)
NT$0
-21.30 (-100.00%)
Price NT$0

7729 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Steminent Biotherapeutics Inc. Key Details

NT$0

Revenue

NT$2.4m

Cost of Revenue

-NT$2.4m

Gross Profit

NT$154.3m

Other Expenses

-NT$156.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-2.35
0%
0%
0%
View Full Analysis

About 7729

Founded
2009
Employees
n/a
CEO
Ling-Mei Wang
WebsiteView website
steminent.com

Steminent Biotherapeutics Inc. operates as a biopharmaceutical company in Taiwan and the United States. It offers Stemchymal, a cell therapy product for the treatment of neurodegenerative diseases, including spinocerebellar ataxia and huntington’s disease; tissue regeneration, such as osteoarthritis; and acute syndromes comprising acute respiratory distress syndrome, liver failure, and ischemic stoke. The company was founded in 2009 and is based in Taipei, Taiwan.

Recent 7729 News & Updates

Recent updates

No updates